Shimokawa H - Search Results

1

Development of Rho-kinase inhibitors for cardiovascular medicine.

Shimokawa H, Rashid M. Shimokawa H, et al. Trends Pharmacol Sci. 2007 Jun;28(6):296-302. doi: 10.1016/j.tips.2007.04.006. Epub 2007 May 7. Trends Pharmacol Sci. 2007. PMID: 17482681 Review.

2

Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries.

Kandabashi T, Shimokawa H, Mukai Y, Matoba T, Kunihiro I, Morikawa K, Ito M, Takahashi S, Kaibuchi K, Takeshita A. Kandabashi T, et al. Among authors: shimokawa h. Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):243-8. doi: 10.1161/hq0202.104274. Arterioscler Thromb Vasc Biol. 2002. PMID: 11834523

3

Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.

Kataoka C, Egashira K, Inoue S, Takemoto M, Ni W, Koyanagi M, Kitamoto S, Usui M, Kaibuchi K, Shimokawa H, Takeshita A. Kataoka C, et al. Among authors: shimokawa h. Hypertension. 2002 Feb;39(2):245-50. doi: 10.1161/hy0202.103271. Hypertension. 2002. PMID: 11847192

4

Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases.

Shimokawa H. Shimokawa H. J Cardiovasc Pharmacol. 2002 Mar;39(3):319-27. doi: 10.1097/00005344-200203000-00001. J Cardiovasc Pharmacol. 2002. PMID: 11862109 Review.

5

Reduction in neointimal formation with a stent coated with multiple layers of releasable heparin in porcine coronary arteries.

Matsumoto Y, Shimokawa H, Morishige K, Eto Y, Takeshita A. Matsumoto Y, et al. Among authors: shimokawa h. J Cardiovasc Pharmacol. 2002 Apr;39(4):513-22. doi: 10.1097/00005344-200204000-00007. J Cardiovasc Pharmacol. 2002. PMID: 11904525

6

Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.

Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Masumoto A, et al. Among authors: shimokawa h. Circulation. 2002 Apr 2;105(13):1545-7. doi: 10.1161/hc1002.105938. Circulation. 2002. PMID: 11927519 Clinical Trial.

7

Inhibition of Rho-kinase induces alphaB-crystallin expression in lens epithelial cells.

Khurana RN, Maddala RL, Shimokawa H, Samuel Zigler J, Epstein DL, Vasantha Rao P. Khurana RN, et al. Among authors: shimokawa h. Biochem Biophys Res Commun. 2002 Jun 28;294(5):981-7. doi: 10.1016/S0006-291X(02)00583-1. Biochem Biophys Res Commun. 2002. PMID: 12074573

8

Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.

Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. Takemoto M, et al. Among authors: shimokawa h. Circulation. 2002 Jul 2;106(1):57-62. doi: 10.1161/01.cir.0000020682.73694.ab. Circulation. 2002. PMID: 12093770

9

Effects of Rho-kinase inhibitor on vasopressin-induced chronic myocardial damage in rats.

Satoh Si, Ikegaki I, Toshima Y, Watanabe A, Asano T, Shimokawa H. Satoh Si, et al. Among authors: shimokawa h. Life Sci. 2002 Nov 22;72(1):103-12. doi: 10.1016/s0024-3205(02)02178-1. Life Sci. 2002. PMID: 12409149

10

Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.

Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, Katagiri T, Yamauchi K, Yui Y, Minamino T, Nakashima M, Kato K. Shimokawa H, et al. J Cardiovasc Pharmacol. 2002 Nov;40(5):751-61. doi: 10.1097/00005344-200211000-00013. J Cardiovasc Pharmacol. 2002. PMID: 12409984 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results